Activation of nitric oxide modulator effect by isometric contraction in rat resistance arteries

Journal of Cardiovascular Pharmacology

Volumn 47, Issue 1, 2006, Pages 51-54

  Rezende, Bruno A ^a   Lemos, Virgínia S ^a   Cortes, Steyner F ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Endothelium; Isometric contraction; Nitric oxide; Protein kinases; Resistance arteries

Indexed keywords

CALPHOSTIN C; ERBSTATIN; ERBSTATIN A; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; STAUROSPORINE; UNCLASSIFIED DRUG; WORTMANNIN; PHENYLEPHRINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL TISSUE; ARTERY RESISTANCE; ARTICLE; CALCIUM CONDUCTANCE; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; MESENTERIC ARTERY; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECT; PHYSIOLOGY; VASCULAR RESISTANCE; VASOCONSTRICTION; WISTAR RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 33646713913     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000194032.20380.c0     Document Type: Article

References (12)

1. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
2. Berk BC, Corson MA, Peterson TE, et al. Protein kinases as mediators of fluid shear stress stimulated signal transduction in endothelial cells: a hypothesis for calcium-dependent and calcium-independent events activated by flow. J Biomech. 1995;28:1439-1450.
3. Dora KA, Hinton JM, Walker SD, et al. An indirect influence of phenylephrine on the release of endothelium-derived vasodilators in rat small mesenteric artery. Br J Pharmacol. 2000;129:381-387.
4. Dimmeler S, Fleming I, Fisslthaler B, et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399:601-605.
5. Fulton D, Gratton JP, McCabe TJ, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999;399:597-601.
6. Vecchione C, Maffei A, Colella S, et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes. 2002;51:168-173.
7. Fleming I, Bauersachs J, Schafer A, et al. Isometric contraction induces the Ca2+-independent activation of the endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 1999;96:1123-1128.
8. Côrtes SF, Rezende BA, Corriu C, et al. Pharmacological evidence for the activation of potassium channels as the mechanism involved in the hypotensive and vasorelaxant effect of dioclein in rat small resistance arteries. Br J Pharmacol. 2001;133:849-858.
9. Mulvany MJ, Halpern WS. Contractile properties of arterial resistance vessels in spontaneously hypertensive rats. Circ Res. 1977;41:19-26.
10. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol. 2003;284:R1-R12.
11. Ayajiki K, Kindermann M, Hecker M, et al. Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ Res. 1996;78:750-758.
12. Hill MM, Hemmings BA. Inhibition of protein kinase B/Akt. Implications for cancer therapy. Pharmacol Ther. 2002;93:243-251.